-
AI Bots and Plagiarism: How Philadelphia and New Jersey News Sites Are Using Fake Content
-
UK House Prices Fall 1.2% as London Records Sharpest Annual Decline
-
The Dice Box Recommends Winter Board Games for Sneinton Market Lounge
-
Get Huge: Looksmaxxing to Death Docuseries Details Tony Huge's Thailand Crimes
-
Government Overspends €607 Million on International Protection Accommodation in 2024
-
IIM Indore Announces IPMAT 2027 Exam Date for April 24
-
Palestinians Salvage Cultural Heritage from Gaza Rubble Amid Widespread Destruction
-
Quick Pressure-Cooker Beef Stew and Rice Minestrone Soup Recipes
-
Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
-
Protagenic Therapeutics Announces Private Placement of Up to $5 Million to Advance PT00114 into Its First U.S. Clinical Trial in Generalized Anxiety Disorder
-
XCF Global Hosts USDA at New Rise Renewables Reno as Facility Surpasses 4.4 Million Gallons Since Restart
-
Valion Bio Reinforces Commitment to American Troops; Discusses Entolimod with Attendees at RW Baird's National Security Conference
-
Green Leaf Innovations (OTC: GRLF) Meets OTCID Disclosure Requirements Following Profitable Q2 2026 Results
-
PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
-
Ethur Takes On Hiring Fraud With Facial Biometrics Identity Checks and Connected Payroll and Bank Data
-
NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
-
Route1 Announces 2026 Annual Meeting Results
-
Healixa's FrostPulse(TM) Technology Solves a Major Roadblock to Data Center Growth: Cooling Without the Water Burden
-
TAMKO and Kansas City Chiefs Announce 2026 Operation Rooftop Recipient
-
AmeriLife Welcomes Finance Veteran Richard Dziadzio as Chief Financial Officer; Names Jim Quinn President & Chief Transformation Officer
-
Trifecta Gold Reports 2026 Exploration Results from the Liam and Lois Projects, Tombstone Gold Belt, Yukon
-
Irving Resources Reports on Drilling in Yamagano Mining Right at the Yamagano Joint Venture, Kyushu, Japan
-
NiobiumX Mining Reports Results of Ground Radiometric Survey at Shipshaw, Maps Two Distinct Radiometric Signatures Across the Core Claims, and Moves to a High-Resolution Airborne Survey of the Full 2,686-Hectare Package
-
BlackBerry to Participate in Upcoming Investor Conferences
-
Christmas Day Shifts More than Double as Americans Return to In-Person Holiday Celebrations
-
THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound
-
Fulcrum Metals PLC Announces Publication of Updated Investor Presentation
-
Guardian Metal Resources PLC Announces Proposed Spin-Out of Non-Tungsten Projects
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 11
-
Fulcrum Metals PLC Announces New Critical Mineral Recoveries Expand Potential
-
6 Pieces of Furniture Worth Investing In
-
5E Advanced Materials to Host Fiscal First Quarter 2027 Earnings Conference Call on November 17, 2026
-
WhalesBot Emphasizes Child Safety and Responsible AI Design in the Development of Pubbo
-
SMX Bridges AI and Industrial Material Science With New Intelligence Platform
-
Moderna Announces JAMA Network Open Publication of Real-World Comparative Effectiveness Data for mNEXSPIKE (COVID-19 Vaccine, mRNA) in Adults Aged 65 Years and Older
-
Sequoia Backs Microsoft Veterans' Edelbyte with $70M to Challenge Data Infrastructure Giants
-
Price Benowitz Earns 2027 Best Law Firm Recognition; 18 Attorneys Recognized by Best Lawyers
-
DaBella Honors More Than 200 Veteran Employees Nationwide This Veterans Day
-
ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
-
Resilient Energy Inc. (OTCID:RENI) Closes Acquisition of Mid River Midstream; Adds 12 Texas SWD Wells and $25M in Assets
-
SMX Expands Technology Portfolio With AI-Powered Scientific Intelligence Platform
-
LA Kush Cake Strain Guide Reviews Genetics and Historical Potency Data
-
Solid Aluminum, Deep Thock and 75% Compact Layout: Meet the Epomaker Galaxy75 Mechanical Keyboard
-
Who Is the Best Facial Feminization Surgeon?
-
CLS Health Advances Construction on New Webster Surgical Campus, Expanding Access to Care in Clear Lake Area
-
Cognitum One Launches Cognitum Spaces, the Governed System of Record for Physical Sites That Gives Enterprise AI Agents Trusted Real-World Context
-
OneMeta Provides Real-Time AI Translation for 2026 G20 Interfaith Forum Summit
-
Cosmos Health Provides U.S. E-Commerce Update for October 2026: Monthly Subscription Value Reaches $1.83 Million, Approximately $22 Million Annualized
-
LiveOne (Nasdaq: LVO) to Report Second Quarter Fiscal 2027 Financial Results on November 12, 2026
-
Arrive AI Announces Strategic Investment in Ottonomy to Accelerate Autonomous Delivery Network Expansion
MD+DI Names Babson Diagnostics, 2024 Medtech Company of the Year
MD+DI editors mark Babson Diagnostics as a notable true solution to deliver simplified blood testing through BetterWay.
Medical Device & Diagnostic Industry (MD+DI), the leading business-to-business media brand covering the medtech industry, has named Babson Diagnostics its 2024 Medtech Company of the Year.
For more than a decade, MD+DI's editors have recognized the Medtech Company of the Year annually to highlight medical device or diagnostic industry players that have risen above the competition with standout technologies, exceptional business results or other achievements. Past winners have included Abbott Laboratories, Boston Scientific and Hologic.
The Medtech Company of the Year selected for 2024 is Babson Diagnostics, in recognition of its BetterWay blood tests, which uses a pea-sized sample of blood collected from a fingertip without the need for a phlebotomist. BetterWay testing launched this year at select locations in Austin, TX, and starts at just $15.
"Babson Diagnostics has tremendously overcome much industry skepticism, due to challenges infamously from other organizations in the past claiming to offer similar premises but never fulfilling the expectations of a seamless, blood testing experience for patients," says Omar Ford, Editor-in-Chief, MD+DI. "BetterWay is a brilliantly simple solution that delivers what was once the dream, to genuinely increase accessibility to patient care, efficiency and personalization, all while being up to half the cost of other self-pay blood tests."
In addition to launching BetterWay tests this past summer, Babson Diagnostics also announced a strategic investment from BD in October. Other milestones for the company this year included validation of its proprietary hand-warming device, which supports improved collection of capillary blood samples, as well as the establishment of a dedicated clinician relations team.
"Almost every conversation we have, some doubt comes into the picture," shares Eric Olson, founder and COO of Babson Diagnostics. "When somebody is trying to understand what we are doing, they always want to know how this compares to other technologies. We realized early on that the way that you deal with that is through science and transparency. It is not enough to just say that we are different than what has happened in the past, in this industry you have to prove it, and we have done just that."
Babson Diagnostics was also selected as The Readers' Choice Medtech Company of the Year, through MD+DI's audience's online vote.
The nine other finalists for the 2024 Medtech Company of the Year were: Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Fractyl, Intuitive Surgical, Medtronic, Senseonics, Solventum and Stryker.
Stay up to date with the latest trends and topics for medical devices and in vitro diagnostic products at: mddionline.com/
About MD+DI
Medical Device and Diagnostic Industry (MD+DI) is the primary resource for manufacturers of medical devices and in vitro diagnostic products. Its mission is to help medtech industry professionals develop, design, and manufacture products that comply with complex and demanding regulations and evolving market requirements. For more than 40 years, MD+DI's editorial quality and reliability have won it an unparalleled degree of trust from the industry. Some of the best and brightest experts in medtech contribute to MD+DI, and many of their articles have become standards of reference for the medical device industry.
Through its associated Qmed+ directory, MD+DI connects readers with qualified suppliers offering the latest products, services and equipment for the medtech industry. As a prominent part of the global Informa Markets - Engineering portfolio, MD+DI is also the official media partner of the MD&M West, MD&M Minneapolis, MD&M East, MD&M South, MEDevice Boston, and MEDevice Silicon Valley events.
Our broader network of related events and media brands serves high-growth industries across the advanced manufacturing sector.
About Informa Markets Engineering
Informa Markets Engineering is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa Markets, a subsidiary of Informa plc (LON:INF), the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.
Media Contact
Informa Markets Engineering PR
[email protected]
SOURCE: INFORMA MARKETS - ENGINEERING
A.Ruiz--AT